comparemela.com

Latest Breaking News On - Centre for commercialization of regenerative medicine - Page 1 : comparemela.com

Two new gene therapies could present cure for sickle cell disease, but access is an obstacle

Cytomos appoints new Commercial and Innovation Officer and Techno-Commercial Adviser: Driving the commercialisation strategy as the company evolves f

23 January 2024: TechBio company, Cytomos (www.cytomotos.com) is pleased to announce the appointment of Dr Fernanda Masri as Chief Commercial and Innovation Officer and Dr Christel Fenge as Techno-Commercial Adviser. In her new role, Fernanda will spearhead Cytomos’ commercialisation strategy, as the company r.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.